Neumann Mark - Insider Transactions
Insider Type
individual
Companies
1
Average
462,155
Total Txns
14
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 2 | -2 | 0.00 | 2,358,151.52 | -2,358,151.52 |
| 2024 | 0 | 12 | -12 | 0.00 | 4,112,015.31 | -4,112,015.31 |
| Total: | 0 | 14 | 10 | 0.00 | 6,470,166.83 | -6,470,166.83 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
75.08 USD |
18,714 Sold |
1,405,047 USD |
16/08/2024 | 16/08/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
65.11 USD |
4,303 Sold |
280,168 USD |
07/03/2024 | 11/03/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
66.37 USD |
8,636 Sold |
573,171 USD |
07/03/2024 | 07/03/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
65.92 USD |
1,729 Sold |
113,976 USD |
07/03/2024 | 11/03/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
66.86 USD |
1,313 Sold |
87,787 USD |
07/03/2024 | 11/03/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
66.95 USD |
4,496 Sold |
301,007 USD |
07/03/2024 | 07/03/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
69.56 USD |
4,059 Sold |
282,344 USD |
23/02/2024 | 26/02/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
70.70 USD |
2,341 Sold |
165,509 USD |
23/02/2024 | 26/02/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
71.18 USD |
1,307 Sold |
93,032 USD |
23/02/2024 | 26/02/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
68.03 USD |
200 Sold |
13,606 USD |
23/02/2024 | 26/02/2024 |